Skip to main content

GSK · GSK plc · Webcasts, Transcripts & Audio

Track GSK — free
$48.58 -0.66 (-1.34%) At close · Nov 18 Q3 2026 earnings call transcript
Market Cap
$97.38B
Shares
2.00B
Volume · Nov 18 2.2M Avg daily vol (3M) 4.03M

GSK plc Webcasts

Earnings calls, investor updates, investor days and conferences for GSK plc (GSK), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q4
2027-02-03
GSK plc (GSK) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-11-17
GSK plc (GSK) November 17, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
GSK plc (GSK) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-28
GSK plc (GSK) Q3 2026 Earnings Call Transcript
Positive tone R&D acceleration Exdensur launch Nucala competition
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-23
GSK plc (GSK) September 23, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
GSK plc (GSK) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
GSK plc (GSK) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-28
GSK plc (GSK) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
GSK plc (GSK) Q1 2026 Earnings Call Transcript
Confident tone HIV long-acting portfolio Specialty Medicines growth Pipeline and R&D priorities
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-04
GSK plc (GSK) Q4 2025 Earnings Call Transcript
Confident tone HIV long-acting portfolio transition Exdensur (depmokimab) launch in respiratory Blenrep launch and ramp
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–10 of 10 webcasts
Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 922 filings 845 filers Visit website Investor relations